These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12694228)

  • 21. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.
    Brunkow ME; Gardner JC; Van Ness J; Paeper BW; Kovacevich BR; Proll S; Skonier JE; Zhao L; Sabo PJ; Fu Y; Alisch RS; Gillett L; Colbert T; Tacconi P; Galas D; Hamersma H; Beighton P; Mulligan J
    Am J Hum Genet; 2001 Mar; 68(3):577-89. PubMed ID: 11179006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syndactyly/brachyphalangy and nail dysplasias as marker lesions for sclerosteosis.
    Itin PH; Keserü B; Hauser V
    Dermatology; 2001; 202(3):259-60. PubMed ID: 11385236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.
    Staehling-Hampton K; Proll S; Paeper BW; Zhao L; Charmley P; Brown A; Gardner JC; Galas D; Schatzman RC; Beighton P; Papapoulos S; Hamersma H; Brunkow ME
    Am J Med Genet; 2002 Jun; 110(2):144-52. PubMed ID: 12116252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of trigeminal neuralgia in sclerosteosis.
    de Andrade EM; Beer-Furlan A; Duarte KP; Fonoff ET; Teixeira MJ
    Surg Neurol Int; 2013; 4(Suppl 6):S455-9. PubMed ID: 24349870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans.
    Boudin E; Yorgan T; Fijalkowski I; Sonntag S; Steenackers E; Hendrickx G; Peeters S; De Maré A; Vervaet B; Verhulst A; Mortier G; D'Haese P; Schinke T; Van Hul W
    J Bone Miner Res; 2017 Aug; 32(8):1739-1749. PubMed ID: 28477420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
    Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
    J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cranial reconstruction for treatment of intracranial hypertension from sclerosteosis: case-based update.
    Tholpady S; Dodd ZH; Havlik RJ; Fulkerson DH
    World Neurosurg; 2014 Feb; 81(2):442.e1-5. PubMed ID: 23182730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurological manifestations in patients and disease carriers in an Italian family with osteosclerosis.
    Bono F; Rapisarda L; Bombardieri C; Gagliardi M; Procopio R; Demonte G; Tosto F; Bruno PA; Gambardella A; Annesi G
    Neurol Sci; 2023 Apr; 44(4):1393-1399. PubMed ID: 36481973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.
    Kim SJ; Bieganski T; Sohn YB; Kozlowski K; Semënov M; Okamoto N; Kim CH; Ko AR; Ahn GH; Choi YL; Park SW; Ki CS; Kim OH; Nishimura G; Unger S; Superti-Furga A; Jin DK
    Hum Genet; 2011 May; 129(5):497-502. PubMed ID: 21221996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sclerosteosis involving the temporal bone: clinical and radiologic aspects.
    Nager GT; Stein SA; Dorst JP; Holliday MJ; Kennedy DW; Diehn KW; Jabs EW
    Am J Otolaryngol; 1983; 4(1):1-17. PubMed ID: 6673595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sclerostin story: from human genetics to the development of novel anabolic treatment for osteoporosis.
    Yavropoulou MP; Xygonakis C; Lolou M; Karadimou F; Yovos JG
    Hormones (Athens); 2014; 13(4):323-37. PubMed ID: 25555179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eighth cranial nerve dysfunction in hyperostosis cranialis interna.
    Manni JJ; Huygen PL; Noten JF; Kuijpers W
    Acta Otolaryngol; 1992; 112(1):75-82. PubMed ID: 1575042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.
    Balemans W; Van Den Ende J; Freire Paes-Alves A; Dikkers FG; Willems PJ; Vanhoenacker F; de Almeida-Melo N; Alves CF; Stratakis CA; Hill SC; Van Hul W
    Am J Hum Genet; 1999 Jun; 64(6):1661-9. PubMed ID: 10330353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
    van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
    J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Basis for Craniofacial Phenotypes Caused by Sclerostin Deletion.
    Chen J; Yuan X; Pilawski I; Liu X; Delgado-Calle J; Bellido T; Turkkahraman H; Helms JA
    J Dent Res; 2021 Mar; 100(3):310-317. PubMed ID: 33078679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.
    Balemans W; Patel N; Ebeling M; Van Hul E; Wuyts W; Lacza C; Dioszegi M; Dikkers FG; Hildering P; Willems PJ; Verheij JB; Lindpaintner K; Vickery B; Foernzler D; Van Hul W
    J Med Genet; 2002 Feb; 39(2):91-7. PubMed ID: 11836356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
    van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW
    Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerosteosis in South Africa.
    Beighton P; Hamersma H
    S Afr Med J; 1979 May; 55(20):783-8. PubMed ID: 223247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oculodento-osseous dysplasia: heterogeneity or variable expression?
    Beighton P; Hamersma H; Raad M
    Clin Genet; 1979 Sep; 16(3):169-77. PubMed ID: 226298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracranial and extracranial reduction osteoplasty for craniodiaphyseal dysplasia.
    Sinow JD; Gruss JS; Roberts TS; Clarren SK; Graham CB; Mouradian W
    Cleft Palate Craniofac J; 1996 Jul; 33(4):284-90. PubMed ID: 8827383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.